Fulgent Genetics (FLGT) Receivables - Other (2016 - 2026)

Fulgent Genetics has disclosed Receivables - Other across 11 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Receivables - Other fell 28.85% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (down 28.85% YoY), while the FY2025 annual figure was $1.1 million, down 35.86% from the prior year.
• Receivables - Other came in at $1.5 million for Q2 2026 at Fulgent Genetics, up from $1.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $19.8 million in Q4 2022 to a low of $699000.0 in Q3 2022.
• Average Receivables - Other over 5 years is $2.4 million, with a median of $1.3 million recorded in 2023.
• Year-over-year, Receivables - Other jumped 3467.63% in 2022 and tumbled 93.35% in 2023.
• Over 5 years, Receivables - Other stood at $19.8 million in 2022, then plunged by 93.35% to $1.3 million in 2023, then soared by 34.04% to $1.8 million in 2024, then sank by 35.86% to $1.1 million in 2025, then gained by 28.75% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Receivables - Other figures were $1.5 million in Q2 2026, $1.1 million in Q1 2026, and $1.1 million in Q4 2025.